0B68 Rosenwasser, Robert H. - Thomas Jefferson University - Thomas Jefferson University
Robert H. Rosenwasser, MD

Robert H. Rosenwasser, MD

Contact Dr. Rosenwasser

909 Walnut Street
3rd Floor
Philadelphia, PA 19107

(215) 955-7000
(215) 503-7038 fax

Most Recent Peer-reviewed Publications

  1. Complications following cranioplasty: incidence and predictors in 348 cases
  2. Safety and efficacy of the Pipeline Embolization Device in 100 small intracranial aneurysms
  3. Neurogenesis is enhanced by stroke in multiple new stem cell niches along the ventricular system at sites of high BBB permeability
  4. Radiosurgery for Spinal Intramedullary Arteriovenous Malformations: A Literature Review
  5. Management of cerebral cavernous malformations: From diagnosis to treatment
  6. Predictors of outcome, complications, and recanalization of the solitaire device: A study of 89 cases
  7. Treatment of ruptured intracranial aneurysms with the pipeline embolization device
  8. The middle meningeal artery as an alternative route for intra-arterial chemotherapy
  9. Flow-diversion for ophthalmic segment aneurysms
  10. Saving the ischemic penumbra: Endovascular thrombolysis versus medical treatment
  11. Intra-Aneurysmal thrombus modification after flow-diversion
  12. Biology of cerebral arteriovenous malformations with a focus on inflammation
  13. Fate of the Ophthalmic Artery after Treatment with the Pipeline Embolization Device
  14. Onyx embolization of a ruptured aneurysm in a patient with moyamoya disease
  15. Stratification of a population of intracranial aneurysms using blood flow metrics
  16. Long-term catheter angiography after aneurysm coil therapy: results of 209 patients and predictors of delayed recurrence and retreatment
  17. Endovascular stroke intervention in the very young
  18. Intra-aneurysmal thrombus modification after flow-diversion
  19. Smoking is a negative predictor of arteriovenous malformation posttreatment obliteration: analysis of vascular risk factors in 774 patients
  20. Flow diversion versus conventional treatment for carotid cavernous aneurysms